Dr. Jonathan Page Voted Most Progressive Researcher
VANCOUVER, Jan. 12, 2018 /PRNewswire/ - Anandia Laboratories Inc. ("Anandia Labs" or the "Company"), a leading cannabis biotechnology and testing company, is pleased to announce that it was voted Top Cannabis Testing Lab in Canada for 2017 at the recent Canadian Cannabis Awards hosted by Lift. In addition, Dr. Jonathan Page, Co-Founder, President and CEO of Anandia Labs, and an internationally-recognized pioneer in cannabis plant biochemistry and genetics, was voted Most Progressive Researcher for 2017 by a committee of cannabis industry professionals.
Dr. Page stated, "We strive to provide exemplary and scientifically rigorous services and we are pleased that the quality of our work – and the contribution of our hard-working staff – has been recognized by our customers. I am very grateful to the awards committee for the award as Most Progressive Researcher which I could not have earned without the support of the outstanding team of scientists at Anandia Labs. Our tagline is "The Science of Better Cannabis"™ and these awards recognize that we live by this in our daily work. I am proud of the achievements of our team and see significant growth ahead for the Company both in Canada as the market shifts to a recreational adult-use framework later this year, and globally, as the demand for Canadian medical cannabis continues to grow."
Anandia Labs is Canada's leading independent cannabis analytics and genetics testing company, with approximately a 20% market share under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company operates out of a 5,400 square foot facility in Vancouver, British Columbia and has plans to construct a 40,000 square foot purpose-built cannabis innovation centre in British Columbia during 2018.
Anandia Labs is 19% owned by CannaRoyalty Corp., an active investor and operator in the legal cannabis industry and a Canadian publicly-traded company (CSE:CRZ) (OTCQX: CNNRF).
About Anandia Labs
Anandia Labs is a biotechnology company focused exclusively on cannabis, with the aim of bringing the best of modern science to the cannabis industry for the benefit of growers and consumers. Anandia Labs provides industry leading analytical testing services including potency, pesticides, microbes and terpenes to Licenced Producers and patients. In addition, Anandia Labs uses its cannabis-specific scientific expertise to assist its customers in the analysis of their testing results and resolution of any detected non-conformities.
Anandia Labs has also completed extensive research into cannabis genetics and has built a significant collection of cannabis germplasm. The Company uses modern plant breeding approaches to develop next generation cannabis varieties. Anandia Labs holds a Dealers Licence by Health Canada pursuant to the provisions of the Controlled Drugs and Substances Act and the Narcotic Control Regulations. The Dealers Licence permits Anandia Labs to analyze and extract cannabis, as well as cultivate cannabis for breeding and strain improvement.
Cautionary Statement on Forward-Looking Information
Certain information contained in this press release, including any information as to Anandia Laboratories Inc's (the "Corporation") strategy, projects, plans or future financial or operating performance, constitutes "forward-looking statements". All statements, other than statements of historical fact, are forward-looking statements. The words "will", "expect", "continue", "assess", and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions that, while considered reasonable by the Corporation as at the date of this press release in light of each of management's experience and perception of current conditions and expected developments, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information.
Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.
SOURCE Anandia Laboratories Inc.